Following are six reasons why pharmaceutical and life sciences companies must prioritize track-and-trace technology in their ...
Taoiseach Micheál Martin is due to meet US President Donald Trump later today in a hotly anticipated meeting as part of St ...
Indian pharmaceutical industry leaders indicate that proposed US tariffs on pharmaceutical exports may lead to increased drug costs and potential shortages in the US. They argue that the tariffs might ...
Tata Consumer Product has a diverse product portfolio, including brands like Tata Tea, Tetley, Tata Salt, and Tata Sampann, which cater to a wide market. The FMCG list of products of Tata Consumer ...
By end user, the CROs/CMOs segment registered the maximum market share in 2024. The U.S. pharmaceutical intermediates market size reached USD 9.3 billion in 2024 and is anticipated to be worth around ...
The guide equips leather industry stakeholders with essential knowledge on ... impacts from the initial extraction of raw materials to the production of finished leather goods across eight impact ...
A new research report exploring the U.S. pharmaceutical market states it had a value of USD 634.34 billion in 2024 and forecasts growth at a compound annual growth rate (CAGR) of 5.73% percent to ...
Mumbai: The Indian Pharmaceutical Market (IPM) began 2025 on a strong note, recording an 8.4% year-on-year growth in January. This growth was largely driven by chronic therapies, which continued to ...
He also stated that he would push for increased European imports of American goods. Trump also revealed plans to impose sector-specific tariffs of at least 25% on pharmaceuticals and semiconductor ...
Stock Market Today: Glenmark Pharmaceuticals share price gained ... The North America registered revenue from the sales of finished dosage formulations of Rs. 781.3 crore for the quarter ended ...
Commenting on the results, Bhushan Akshikar, MD of GlaxoSmithKline Pharmaceuticals, highlighted the company’s strategic initiatives in strengthening its market presence and enhancing access to ...